The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer
- PMID: 15337041
- DOI: 10.1016/j.athoracsur.2004.02.067
The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer
Abstract
Background: The treatment of patients with nonsmall cell lung cancer (NSCLC) is determined by the stage. We evaluated the accuracy of staging using integrated positron emission tomography (PET) and computed tomography (CT) and compared it with dedicated PET visually correlated with CT scan.
Methods: A prospective blinded trial was performed on a consecutive series of patients with NSCLC. Patients underwent integrated PET-CT scanning with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG-18). A radiologist assigned the T, N and M status. No sooner than 2 weeks the same radiologist read the dedicated PET alone, without the integrated CT images and a T, N and M status was assigned again. The most recent CT scan was available and visually correlated with both studies. All patients underwent biopsies of suspicious N2 or N3 lymph node or distant metastases and if negative, pulmonary resection with lymphadenectomy was performed.
Results: There were 129 patients. Integrated PET-CT is a better predictor than PET for all stages of cancer and achieved statistical significance for stage I (52% versus 33%, p = 0.03) and for stage II (70% versus 36%, p = 0.04). It also is a better overall predictor for T status (70% versus 47%, p = 0.001) and the N status (78% versus 56%, p = 0.008). Nodal analysis shows that integrated PET-CT was more accurate for the total N2 nodes (96% versus 93%, p = 0.01) and for the total N1 nodes (90% versus 80%, p = 0.001). It was also more sensitive, specific, and had a higher positive predictive value for both N2 and N1 nodes (p < 0.05 for all). Integrated PET-CT is significantly more sensitive at the 4R, 5, 7, 10 L and 11 stations and more accurate at the 7 and 11 lymph nodes stations than dedicated PET.
Conclusions: Integrated PET-CT using FDG-18 better predicts stage I and II disease as well as the T and N status of patients with NSCLC when compared with dedicated PET alone. It is more accurate at some nodal stations but still only achieves an accuracy of 96% and 90% for the N2 and N1 nodes, respectively.
Similar articles
-
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Eur J Cardiothorac Surg. 2009. PMID: 19464906 Review.
-
Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.Lung Cancer. 2008 Jul;61(1):35-43. doi: 10.1016/j.lungcan.2007.11.007. Epub 2008 Jan 4. Lung Cancer. 2008. PMID: 18177978
-
Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.Chin Med J (Engl). 2009 Aug 5;122(15):1749-54. Chin Med J (Engl). 2009. PMID: 19781319
-
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.N Engl J Med. 2003 Jun 19;348(25):2500-7. doi: 10.1056/NEJMoa022136. N Engl J Med. 2003. PMID: 12815135
-
Virtual 18F-FDG PET/CT bronchoscopy for lymph node staging in non-small-cell lung cancer patients: present and future applications.Expert Rev Med Devices. 2012 May;9(3):241-7. doi: 10.1586/erd.12.9. Expert Rev Med Devices. 2012. PMID: 22702254 Review.
Cited by
-
Construction and Evaluation of a Preoperative Prediction Model for Lymph Node Metastasis of cIA Lung Adenocarcinoma Using Random Forest.J Oncol. 2022 Sep 25;2022:4008113. doi: 10.1155/2022/4008113. eCollection 2022. J Oncol. 2022. PMID: 36199801 Free PMC article.
-
The developing role of FDG PET imaging for prognostication and radiotherapy target volume delineation in non-small cell lung cancer.J Thorac Dis. 2018 Aug;10(Suppl 21):S2508-S2521. doi: 10.21037/jtd.2018.07.101. J Thorac Dis. 2018. PMID: 30206495 Free PMC article. Review.
-
Performance of [18F]FDG PET/CT versus FAPI PET/CT for lung cancer assessment: a systematic review and meta-analysis.Eur Radiol. 2024 Feb;34(2):1077-1085. doi: 10.1007/s00330-023-10013-7. Epub 2023 Aug 17. Eur Radiol. 2024. PMID: 37589901
-
Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data.Oncologist. 2011;16(5):672-81. doi: 10.1634/theoncologist.2010-0150. Epub 2011 Mar 4. Oncologist. 2011. PMID: 21378080 Free PMC article. Review.
-
18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity.Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1794-802. doi: 10.1007/s00259-009-1155-4. Epub 2009 May 9. Eur J Nucl Med Mol Imaging. 2009. PMID: 19430783 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical